Zhejiang Starry Pharmaceutical Co., Ltd.SSE: 603520

Announcement on Outward Investment and Related Party Transactions

· Issued by Zhejiang Starry Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 11 pages · Chinese

Summary by 6ix AI

The company plans to invest a significant amount of its own funds to acquire a minority stake in Jianli Chemical, which is considered a related party transaction due to existing connections with key stakeholders. This investment does not require shareholder approval as it does not exceed regulatory thresholds for significant asset restructuring. The announcement includes risk factors associated with the investment, emphasizing the need for careful monitoring of external conditions and company management.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Outward Investment and Related Party Transactions

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Starry Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhejiang Starry Pharmaceutical

Later from Zhejiang Starry Pharmaceutical

All Zhejiang Starry Pharmaceutical news releases